Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for Pazopanib hydrochloride in metastatic or recurrent kidney cancers have been posted after the study completed, including collecting duc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chromophobe Renal Cell Carcinoma
• Collecting Duct Carcinoma
• Medullary Carcinoma of the Kidney
• Papillary Renal Cell Carcinoma
• Renal Cell Carcinoma
• Renal Oncocytoma
• Sarcomatoid Renal Cell Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Mayo Clinic | Conditions: Carcinoma of the Collecting Ducts of Bellini, Chromophobe Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-04-08